# Virginia Tech Researchers Discuss Cannabis Impact on Driving – WSLS > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-driving-impairment-study-virginia-tech/ > **Published:** 2026-04-24T13:18:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:27:24-04:00 > **Clinical Summary:** Explore the cannabis driving impairment study by Virginia Tech researchers assessing how cannabis use affects driving safety and performance. --- ✦ New CED Clinical Relevance** #50 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. ResearchSafetyPolicy Clinical Summary Researchers at Virginia Tech have developed a novel methodology for evaluating the effects of cannabis use on driving performance, addressing a significant gap in objective safety assessment. The study design employs controlled laboratory and driving simulator conditions to measure impairment markers such as reaction time, vehicle control, and decision-making under the influence of cannabis. These findings are clinically relevant as physicians increasingly encounter patients using cannabis for medical purposes who may be operating vehicles, and objective data on impairment can inform better patient counseling regarding safety risks. Current limitations in assessing cannabis-induced driving impairment have made it difficult for clinicians to provide evidence-based guidance comparable to alcohol screening. Understanding standardized methods to measure cannabis-related driving impairment could help clinicians counsel patients more effectively about when to avoid driving after use and identify high-risk individuals. Clinicians should familiarize themselves with emerging impairment assessment tools so they can provide patients with science-based recommendations about cannabis use and driving safety. Dr. Caplan’s Take “What Virginia Tech’s research clarifies is that we still lack the standardized objective measures in clinical practice that we have for alcohol, which means I’m having to make driving safety assessments based on patient honesty and observation alone, and that’s a significant gap in how I counsel patients about their real-world impairment risk.” Clinical Perspective As [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) expands across the United States, understanding its impact on driving impairment becomes increasingly relevant to clinical practice, yet this remains an area where robust epidemiological methods are still evolving. Virginia Tech’s work on studying cannabis-related driving impairment highlights a critical gap in clinical knowledge: unlike alcohol, we lack standardized biomarkers that reliably correlate blood cannabinoid levels with impairment or accident risk, making it difficult to counsel patients about safe driving windows after use. The heterogeneity of cannabis products, individual tolerance variation, and the distinction between acute intoxication and residual impairment further complicate any clinical guidance. Clinicians should be aware that current roadside testing and legal THC thresholds remain scientifically contentious, and patients may receive inconsistent information from law enforcement, regulators, and healthcare sources. Given these uncertainties, a practical approach is to counsel cannabis users— 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Virginia+Tech+researchers+discuss+method+used+to+%3Cb%3Estudy%3C%2Fb%3E+how+%3Cb%3Ecannabis%3C%2Fb%3E+usage+impacts+driv...+%40drcaplan&url=https%3A%2F%2Fwww.wsls.com%2Fnews%2Flocal%2F2026%2F03%2F01%2Fvirginia-tech-researchers-discuss-method-used-to-study-how-cannabis-usage-impacts-driving%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.wsls.com%2Fnews%2Flocal%2F2026%2F03%2F01%2Fvirginia-tech-researchers-discuss-method-used-to-study-how-cannabis-usage-impacts-driving%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Virginia+Tech+researchers+discuss+method+used+to+%3Cb%3Estudy%3C%2Fb%3E+how+%3Cb%3Ecannabis%3C%2Fb%3E+usage+impacts+driv...+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.wsls.com%2Fnews%2Flocal%2F2026%2F03%2F01%2Fvirginia-tech-researchers-discuss-method-used-to-study-how-cannabis-usage-impacts-driving%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - First-of-its-kind long-term study** at Virginia Tech shares how **cannabis** use can affect driving - [#ICYMI Our Zoe Mowery explored a pioneering Virginia Tech study on how cannabis use …](https://cedclinic.com/virginia-tech-cannabis-study-clinical-relevance/) - [#ICYMI Our Zoe Mowery explored a pioneering Virginia Tech study on how cannabis use …](https://cedclinic.com/virginia-tech-cannabis-study-clinical-relevance/) 📰 Source: [https://www.wsls.com/news/local/2026/03/01/virginia-tech-researchers-discuss-method-used-to-study-how-cannabis-usage-impacts-driving/](https://www.wsls.com/news/local/2026/03/01/virginia-tech-researchers-discuss-method-used-to-study-how-cannabis-usage-impacts-driving/) Further Reading Evidence Watch[Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States.](https://cedclinic.com/cannabis-rescheduling-public-comments-analysis-2024/) Research Digest[Research Digest: 10 Recent Studies – April 22, 2026](https://cedclinic.com/recent-cannabinoid-clinical-research-april-2026/) Cannabis Policy WireCED Regulatory Digest, Since Last Digest, 1 items [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Virginia agency launches campaign against driving after using cannabis – WVTF](https://cedclinic.com/cannabis-impaired-driving-risks-safety-campaign-virginia/) Learn about Virginia's efforts to reduce driving after cannabis use through public safety campaigns. [Read More](https://cedclinic.com/cannabis-impaired-driving-risks-safety-campaign-virginia/) [Cannabis testing challenges persist as Virginia retail market nears](https://cedclinic.com/2026-cannabis-testing-challenges-virginia-retail-market/) Explore ongoing challenges in cannabis testing that impact safety and regulation in Virginia. [Explore Article](https://cedclinic.com/2026-cannabis-testing-challenges-virginia-retail-market/) [Advanced drug testing improves patient care at MUSC](https://cedclinic.com/advanced-cannabis-testing-methods-musc-patient-care/) Discover how advanced [drug testing](https://cedclinic.com/how-long-does-weed-stay-in-your-system/) methods enhance clinical care and patient safety. [Learn More](https://cedclinic.com/advanced-cannabis-testing-methods-musc-patient-care/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).